Human Vaccines-Infectious & non-Infectious


Finally, the ability of the immune system to recognize a tumor-associated antigen, thus enabling development of a vaccine approach for therapeutic application, represents a main target of this field of research. Long years of research were required for busting the new system to fight cancer. ast year over 800 million doses of combination vaccines are used to vaccinate Chinese children whereas more than 20 million children worldwide do not receive one or more important vaccinations that would protect them from at least one preventable disease. HBV virus, the viola major, the virus that causes the smallpox, lethal virus in the 30% of the cases, was eradicated in 1979 in the human species, thanks to a capillary vaccination on global scale. Thus enabling development of a vaccine approach for therapeutic application represents a main target of this field of research.



 


  • Cancers.
  • Systemic lupus erythematous(lupus)
  • Certain medicines
  • Head injury.
  • Brain surgery
  • Bacteria Cultures Based Vaccines

Related Conference of Human Vaccines-Infectious & non-Infectious

May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland
October 24-25, 2024

5th International Conference on Immunology And Immunotherapy

Zurich, Switzerland

Human Vaccines-Infectious & non-Infectious Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in